Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology

BackgroundWith the emergence of disease-modifying therapies for Alzheimer’s disease (AD), there is an urgent need for scalable, accurate, and well-validated blood test alternatives to positron emission topography (PET) and lumbar punctures for identifying amyloid pathology to facilitate identificati...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	David Wilson, Meenakshi Khare, Gallen Triana-Baltzer, Michele Wolfe, Patrick Sheehy, Karen Copeland, Lyndal Hesterberg, Ann-Jeanette Vasko, Wiesje M. van der Flier, Inge M. W. Verberk, Charlotte E. Teunissen, Mike Miller
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-07-01
Sarja:	Frontiers in Neurology
Aiheet:	Alzheimer’s disease immunoassay p-Tau 217 validation amyloid Simoa
Linkit:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1568971/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!